NGL Fine-Chem Limited (NSE:NGLFINE)
India · Delayed Price · Currency is INR 2,801.00
+299.10 (11.95%)
May 22, 2026, 3:29 PM IST
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 17.11 billion as of May 22, 2026. Its market cap has increased by 148.01% in one year.
Market Cap
17.11B
Enterprise Value
17.76B
Revenue
5.16B
Ranking
n/a
PE Ratio
35.56
Stock Price
2,801.00
Market Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 17.11B, an increase of 21,185.75%. That is a compound annual growth rate of 28.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 17.11B | 96.60% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.43T |
| Divi's Laboratories | 1.83T |
| Apollo Hospitals Enterprise | 1.20T |
| Cipla | 1.13T |
| Indoco Remedies | 18.38B |
| Shalby | 18.37B |
| Krsnaa Diagnostics | 18.25B |
| Sakar Healthcare | 16.95B |